REQUEST A DEMO
Total
USD $0.00
Search more companies

Celest Pharma Labs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Celest Pharma Labs Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Celest Pharma Labs Private Limited is an unlisted company, incorporated on 17/03/2010. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U24230KA2010PTC052859 and registration number is 052859. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
No. 68, Ground Floor, 6Th Main, 3Rd Phase, Peenya Industrial Area,
Bangalore; Karnataka; Postal Code: 560058

Contact Details: Purchase the Celest Pharma Labs Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Celest Pharma Labs Private Limited report to view the information.
Registered Capital:
Purchase the Celest Pharma Labs Private Limited report to view the information.
Incorporation Date:
March 17, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Celest Pharma Labs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-46.53%
Total operating revenue
-46.43%
Operating profit (EBIT)
-81.53%
EBITDA
-73.76%
Net Profit (Loss) for the Period
-81.13%
Total assets
46.64%
Total equity
3.2%
Operating Profit Margin (ROS)
-2.7%
Net Profit Margin
-1.96%
Return on Equity (ROE)
-13.86%
Debt to Equity Ratio
65.44%
Quick Ratio
-0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?